Skip to content

Clinical trials

Phase 2 Adenoma, Islet Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenoma, Islet Cell Phase: Phase 2 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20061
20081
20102
20111
20121
20131
20151
20171
20191
20212
20222
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting4
Recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute2
H. Lee Moffitt Cancer Center and Research Institute2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
University of Washington2
Vanderbilt-Ingram Cancer Center2
Aadi Bioscience, Inc.1
Alliance for Clinical Trials in Oncology1
ECOG-ACRIN Cancer Research Group1
Eastern Cooperative Oncology Group1
Endeavor Biomedicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenoma, Islet Cell24
Neuroendocrine Tumors7
Gastrinoma6
Somatostatinoma6
Carcinoid Tumor5
Carcinoma, Islet Cell5
Glucagonoma5
Insulinoma5
Neoplasm Metastasis5
Neoplasms4

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.